Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study

Author:

Wallace Zachary S.1ORCID,Harkness Tyler2,Fu Xiaoqing2,Stone John H.1ORCID,Choi Hyon K.1ORCID,Walensky Rochelle P.1

Affiliation:

1. Massachusetts General Hospital and Harvard Medical School Boston Massachusetts

2. Massachusetts General Hospital Boston

Funder

Rheumatology Research Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Massachusetts General Hospital

Publisher

Wiley

Subject

Rheumatology

Reference36 articles.

1. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults;Ruiz Garcia V;Cochrane Database Syst Rev,2017

2. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis;Singh JA;Cochrane Database Syst Rev,2017

3. Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis

4. Rituximab in ANCA-Associated Vasculitis

5. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3